Cell Biology International · 2014 · 16 citations · 10 references
Life SciencesMolecular BiologyOncologyEpigeneticsEpigenomicsMolecular OncologyApoptosis In CancerCancer EpigeneticsCancer EpigenomicsCancer TranscriptomicsEpigenetic Alterations In CancerEpigenetic Regulation In CancerAnti-apoptotic ProteinsApoptotic Signaling In CancerApoptotic Signaling PathwaysEpigenetic Silencing Of Tumor Suppressor GenesEpigenomic SignaturesOncogenic TransformationTranscriptome AnalysisTumor Suppressor Pathways
Since apoptosis presents a natural defense in cancer development, the anti-apoptotic factor AATF/Che-1 has emerged as a crucial 'Epigenomic-Switch'. We have tried to understand the double-edged nature of AATF, showing for the first time the conspicuous existence of an aberrant AATF/Che-1 transcriptome encoding for 23 kDa mutant AATF protein, which evolves its unique interactome within human cancer cells derived from different tissue origins. This mutant AATF along with its interactome consisting of SP1, DNMT3B and Par-4 ensures cancer cell DNA methylation required for down-regulation of tumor suppressor genes. Hence, the proposed mutant AATF interactome-based pathway can have the inherent ability to ensure human cells become and remain cancerous.
10
Regulation of autophagy by cytoplasmic p53
Ezgi Tasdemir, Maria Chiara Maiuri, Lorenzo Galluzzi et al. · Nature Cell Biology · 2008 · 1.1K citations · Full text
A dual role of p53 in the control of autophagy
Ezgi Tasdemir, Maria Chiara Maiuri, Eugenia Morselli et al. · Autophagy · 2008 · 335 citations · Full text
Kevin Pruitt, Aylin S. Ülkü, Karen Frantz et al. · Journal of Biological Chemistry · 2005 · 94 citations · Full text